JP2003500010A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003500010A5 JP2003500010A5 JP2000604066A JP2000604066A JP2003500010A5 JP 2003500010 A5 JP2003500010 A5 JP 2003500010A5 JP 2000604066 A JP2000604066 A JP 2000604066A JP 2000604066 A JP2000604066 A JP 2000604066A JP 2003500010 A5 JP2003500010 A5 JP 2003500010A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acids
- mature
- seq
- polypeptide
- segment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001413 amino acids Chemical class 0.000 description 32
- 108090000765 processed proteins & peptides Proteins 0.000 description 28
- 229920001184 polypeptide Polymers 0.000 description 26
- 102000004196 processed proteins & peptides Human genes 0.000 description 26
- 241000288906 Primates Species 0.000 description 18
- 102000039446 nucleic acids Human genes 0.000 description 15
- 108020004707 nucleic acids Proteins 0.000 description 15
- 150000007523 nucleic acids Chemical class 0.000 description 15
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 14
- 102100038493 Cytokine receptor-like factor 1 Human genes 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 14
- 101710194728 Cytokine receptor-like factor 1 Proteins 0.000 description 13
- 238000000034 method Methods 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 9
- 239000000427 antigen Substances 0.000 description 5
- 102000036639 antigens Human genes 0.000 description 5
- 108091007433 antigens Proteins 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000006461 physiological response Effects 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26790199A | 1999-03-11 | 1999-03-11 | |
| US09/267,901 | 1999-03-11 | ||
| PCT/US2000/006182 WO2000053631A1 (en) | 1999-03-11 | 2000-03-09 | Mammalian cytokines; related reagents and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003500010A JP2003500010A (ja) | 2003-01-07 |
| JP2003500010A5 true JP2003500010A5 (enExample) | 2007-05-10 |
Family
ID=23020618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000604066A Pending JP2003500010A (ja) | 1999-03-11 | 2000-03-09 | 哺乳動物サイトカイン；関連試薬および方法 |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP1942114A3 (enExample) |
| JP (1) | JP2003500010A (enExample) |
| AR (1) | AR022890A1 (enExample) |
| AT (1) | ATE420894T1 (enExample) |
| AU (1) | AU3873200A (enExample) |
| CA (1) | CA2366706A1 (enExample) |
| DE (1) | DE60041393D1 (enExample) |
| ES (1) | ES2319958T3 (enExample) |
| WO (1) | WO2000053631A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2804435A1 (fr) * | 2000-01-27 | 2001-08-03 | Pf Medicament | COMPLEXE ISOLE COMPRENANT UNE PROTEINE NNT-1 ET EN OUTRE AU MOINS UNE PROTEINE CLF-1 ET/OU UNE PROTEINE sCNTFRalpha |
| US7045283B2 (en) * | 2000-10-18 | 2006-05-16 | The Regents Of The University Of California | Methods of high-throughput screening for internalizing antibodies |
| AU2004239288B2 (en) | 2003-05-09 | 2010-01-28 | Centocor, Inc. | IL-23p40 specific immunoglobulin derived proteins, compositions, methods and uses |
| AR051444A1 (es) | 2004-09-24 | 2007-01-17 | Centocor Inc | Proteinas derivadas de inmunoglobulina especifica de il-23p40, composiciones, epitopos, metodos y usos |
| PT1896073E (pt) | 2005-06-30 | 2013-05-28 | Janssen Biotech Inc | Composições, métodos e aplicações de anticorpos anti-il-23 |
| ME02705B (me) | 2005-08-31 | 2017-10-20 | Merck Sharp & Dohme | Inženjerisana anti-il-23 antitela |
| PT2548577T (pt) | 2005-12-29 | 2017-05-29 | Janssen Biotech Inc | Anticorpos humanos anti-il-23, composições, métodos e usos |
| SI2426144T1 (sl) | 2007-02-23 | 2019-02-28 | Merck Sharp & Dohme Corp. | Umetno proizvedena anti-IL23P19 antitelesa |
| CN101663320A (zh) | 2007-02-23 | 2010-03-03 | 先灵公司 | 工程改造的抗IL-23p19抗体 |
| US8119133B2 (en) | 2007-02-28 | 2012-02-21 | Schering Corporation | Engineered anti-IL-23R antibodies |
| CN101668531B (zh) | 2007-02-28 | 2014-05-07 | 默沙东公司 | 用于治疗免疫病症的联合治疗 |
| WO2014004436A2 (en) | 2012-06-27 | 2014-01-03 | Merck Sharp & Dohme Corp. | Crystalline anti-human il-23 antibodies |
| UA117466C2 (uk) | 2012-12-13 | 2018-08-10 | Мерк Шарп Енд Доме Корп. | СТАБІЛЬНИЙ СКЛАД У ВИГЛЯДІ РОЗЧИНУ АНТИТІЛА ДО IL-23p19 |
| JOP20190260A1 (ar) | 2017-05-02 | 2019-10-31 | Merck Sharp & Dohme | صيغ ثابتة لأجسام مضادة لمستقبل الموت المبرمج 1 (pd-1) وطرق استخدامها |
| US11845798B2 (en) | 2017-05-02 | 2023-12-19 | Merck Sharp & Dohme Llc | Formulations of anti-LAG3 antibodies and co-formulations of anti-LAG3 antibodies and anti-PD-1 antibodies |
| KR20210089215A (ko) | 2018-11-07 | 2021-07-15 | 머크 샤프 앤드 돔 코포레이션 | 항-lag3 항체 및 항-pd-1 항체의 공동-제제 |
| IL283192B2 (en) | 2018-11-20 | 2025-10-01 | Janssen Biotech Inc | A safe and effective method for treating psoriasis with a specific anti-IL-23 antibody |
| MX2021014302A (es) | 2019-05-23 | 2022-01-04 | Janssen Biotech Inc | Metodo para tratar la enfermedad inflamatoria del intestino con una terapia de combinacion de anticuerpos contra il-23 y tnf alfa. |
| CN115768466A (zh) | 2020-05-21 | 2023-03-07 | 詹森生物科技公司 | 用抗IL-23和TNFα抗体的联合疗法治疗炎性肠病的方法 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3940475A (en) | 1970-06-11 | 1976-02-24 | Biological Developments, Inc. | Radioimmune method of assaying quantitatively for a hapten |
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
| US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
| US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
| ATE64618T1 (de) | 1982-03-15 | 1991-07-15 | Schering Corp | Hybride dns, damit hergestellte bindungszusammensetzung und verfahren dafuer. |
| US4659678A (en) | 1982-09-29 | 1987-04-21 | Serono Diagnostics Limited | Immunoassay of antigens |
| NZ207394A (en) | 1983-03-08 | 1987-03-06 | Commw Serum Lab Commission | Detecting or determining sequence of amino acids |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4859609A (en) | 1986-04-30 | 1989-08-22 | Genentech, Inc. | Novel receptors for efficient determination of ligands and their antagonists or agonists |
| US5470952A (en) * | 1993-10-20 | 1995-11-28 | Regeneron Pharmaceuticals, Inc. | CNTF and IL-6 antagonists |
| DE69637599D1 (de) * | 1995-08-01 | 2008-08-21 | Hoffmann La Roche | Rezeptoren für das humane Interleukin-12 |
| AUPO224696A0 (en) * | 1996-09-11 | 1996-10-03 | Amrad Operations Pty. Limited | A novel haemopoietin receptor and genetic sequences encoding same |
| WO1998031811A1 (en) * | 1997-01-16 | 1998-07-23 | Genetics Institute, Inc. | Member of the hematopoietin receptor superfamily |
| CN1195853C (zh) * | 1997-02-03 | 2005-04-06 | 安姆根有限公司 | 神经营养因子nnt－1 |
| US5741772A (en) * | 1997-02-03 | 1998-04-21 | Amgen Inc. | Neurotrophic factor NNT-1 |
| WO1998049307A1 (en) * | 1997-05-01 | 1998-11-05 | Zymogenetics, Inc. | Mammalian cytokine-like receptor |
| EP1001982A1 (en) * | 1997-06-30 | 2000-05-24 | Human Genome Sciences, Inc. | Cardiotrophin-like cytokine |
| GB9721961D0 (en) * | 1997-10-16 | 1997-12-17 | Glaxo Group Ltd | Novel molecules |
| IL136216A0 (en) * | 1997-12-03 | 2001-05-20 | Genentech Inc | Polypeptides and nucleic acids encoding the same |
| AU2454399A (en) * | 1998-01-09 | 1999-07-26 | Immunex Corporation | H14 dna and polypeptides |
| AU2661199A (en) * | 1998-02-06 | 1999-08-23 | Schering Corporation | Mammalian receptor proteins; related reagents and methods |
| EP2258849A1 (en) * | 1999-06-01 | 2010-12-08 | Schering Corporation | Mammalian receptor proteins; related reagents and methods |
| FR2804435A1 (fr) * | 2000-01-27 | 2001-08-03 | Pf Medicament | COMPLEXE ISOLE COMPRENANT UNE PROTEINE NNT-1 ET EN OUTRE AU MOINS UNE PROTEINE CLF-1 ET/OU UNE PROTEINE sCNTFRalpha |
-
2000
- 2000-03-09 DE DE60041393T patent/DE60041393D1/de not_active Expired - Lifetime
- 2000-03-09 WO PCT/US2000/006182 patent/WO2000053631A1/en not_active Ceased
- 2000-03-09 EP EP08103087A patent/EP1942114A3/en not_active Withdrawn
- 2000-03-09 AU AU38732/00A patent/AU3873200A/en not_active Abandoned
- 2000-03-09 AR ARP000101059A patent/AR022890A1/es unknown
- 2000-03-09 ES ES00917821T patent/ES2319958T3/es not_active Expired - Lifetime
- 2000-03-09 AT AT00917821T patent/ATE420894T1/de not_active IP Right Cessation
- 2000-03-09 EP EP00917821A patent/EP1159299B1/en not_active Expired - Lifetime
- 2000-03-09 JP JP2000604066A patent/JP2003500010A/ja active Pending
- 2000-03-09 CA CA002366706A patent/CA2366706A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003500010A5 (enExample) | ||
| Yamasaki et al. | Identification of four nuclear transport signal-binding proteins that interact with diverse transport signals | |
| JP2004509617A5 (enExample) | ||
| JP2003534013A5 (enExample) | ||
| JPH02500329A (ja) | ターゲット化多機能蛋白質 | |
| JP2002508933A (ja) | 二官能分子 | |
| CN113698475B (zh) | 抗猪δ冠状病毒N蛋白的单克隆抗体和猪δ冠状病毒胶体金快速检测试纸条 | |
| CA2240409A1 (en) | Mammalian cx3c chemokine genes | |
| WO2004067564B1 (en) | Compositions against cancer antigen liv-1 and uses thereof | |
| CN115286715B (zh) | 一种抗cd3的纳米抗体或其抗原结合部分及其制备方法 | |
| Ståhl et al. | Engineered bacterial receptors in immunology | |
| CN109293739B (zh) | 一种a3超家族通用肿瘤抗原多肽及其应用 | |
| EP0646173A1 (en) | Reagent for agglutination assays | |
| CN114736292A (zh) | 靶向诺如病毒蛋白的纳米抗体及其应用 | |
| CN106928358B (zh) | 一种CD105纳米抗体Nb168 | |
| CN116813765B (zh) | Rab8蛋白的特异性抗体及其制备方法与应用 | |
| CN106928355B (zh) | 一种CD105纳米抗体Nb184 | |
| CN116284424A (zh) | 抗鼠抗体可结晶段的纳米抗体及其应用 | |
| CN120518757B (zh) | 一种聚乙二醇化多价抗西尼罗病毒单链抗体 | |
| CN116640209B (zh) | Rab11蛋白的特异性抗体及其制备方法与应用 | |
| CN102276700A (zh) | 一种猪戊型肝炎病毒抗原表位及它的应用 | |
| CN106928359B (zh) | 一种CD105纳米抗体Nb59 | |
| JP2002510712A5 (enExample) | ||
| CN102268078B (zh) | 一种猪戊型肝炎病毒抗原表位及其应用 | |
| WO1998036076A1 (en) | Modified treponema pallidum-derived antigen protein |